Home › Dermatomyositis › Texas › Houston
Dermatomyositis clinical trials in Houston, TX
5 studies for Dermatomyositis are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- UT MD Anderson Cancer Center, Houston
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
RecruitingPhase 2/3
- Houston Methodist Hospital - Accepting Adult Patients, Houston
- University of Texas MD Anderson Cancer Center - Accepting Adult Patients, Houston
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
RecruitingPhase 3
- Nerve & Muscle Center of Texas, Houston
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
RecruitingPhase 3
- Nerve & Muscle Center of Texas, Houston
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
RecruitingPhase 1
- Nerve and Muscle Center of Texas, Houston
Dermatomyositis trials in other cities
- Durham, NC8 studies
- Washington, DC7 studies
- Pittsburgh, PA5 studies
- Boston, MA5 studies
- New York City, NY5 studies
- Miami, FL4 studies
- Philadelphia, PA4 studies
- Baltimore, MD4 studies
- Phoenix, AZ3 studies
- Jacksonville, FL3 studies
- Cleveland, OH3 studies
- Kansas City, KS3 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)122 studies
- Metastatic Cancer104 studies
- Colorectal Cancer103 studies
- Ovarian Cancer90 studies
- Acute Myeloid Leukemia86 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer69 studies
- Pancreatic Cancer62 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.